FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 20:46:18 23/05/2024 BST | ||
| 2.56 EUR | +11.30% |
|
| Current month | -77.39% | ||
| 1 month | -78.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 2.56 | +11.30% |
| 22/05/24 | 2.3 | +2.68% |
| 21/05/24 | 2.24 | -2.61% |
| 20/05/24 | 2.3 | -0.86% |
| 17/05/24 | 2.32 | +3.57% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 08:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEH |
| ISIN | DE000HD2VEH6 |
| Date issued | 21/02/2024 |
| Strike | 371.3 $ |
| Maturity | Unlimited |
| Parity | 25.03 : 1 |
| Emission price | 10.39 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.56 € |
|---|---|
| Lowest since issue | 2.13 € |
| Spread | 0.01 € |
| Spread % | 0.39% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306.5
USD
Average target price
316.1
USD
Spread / Average Target
+3.12%
- Stock Market
- Certificates
- Certificat
